Skip to main content
DRMA logo
DRMA
(NASDAQ)
Dermata Therapeutics, Inc.
$1.16-- (--)
Loading... - Market loading

Dermata Therapeutics (DRMA) Company Profile

Complete business overview, executive team, trading details, and corporate information.

Dermata Therapeutics, Inc.
DRMANasdaq Stock MarketHealthcareBiotechnology

About Dermata Therapeutics

Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States. The company develops direct-to-consumer skincare products, including foundation treatment products for skin renewal and clearing treatment products for the treatment of acne under the Tome brand. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.

Company Information

CEOGerald Proehl
Founded2014
IPO DateAugust 13, 2021
Employees9
CountryUnited States
Fiscal YearJanuary - December

Stock Details

ExchangeNasdaq Stock Market (NASDAQ)
CurrencyUSD - USD
TypeStock
SubtypeCommon Stock

Contact Information

Phone858 800 2543
Address
3525 Del Mar Heights Rd., Suite 332 San Diego, California 92130 United States

Corporate Identifiers

CIK0001853816
CUSIP249845504
ISINUS2498455045
SIC2834

Leadership Team & Key Executives

Gerald T. Proehl
Founder, President, Chief Executive Officer and Chairman
David F. Hale
Co-Founder and Lead Independent Director
Kyri K. Van Hoose CPA, M.B.A.
Senior Vice President and Chief Financial Officer
Dr. Christopher J. Nardo M.P.H., Ph.D.
Senior Vice President and Chief Development Officer
Sean Proehl
Associate General Counsel
Kyra Peckaitis
Vice President of Marketing
Dr. Maria Bedoya Toro Munera M.B.A., Ph.D.
Senior Vice President of Regulatory Affairs and Quality Assurance